C21 · Pharmaceuticals · CN

Clinical trial starts in China

China: 16 (alzheimer's disease drug trial starts, 2025), +14.3% on 2024.

  • 16 Latest · 2025
  • +14.3% vs 2024
  • 70Records · 10 measures

Annual · 1 publisher · Next period 2026

Alzheimer's disease drug trial starts in China

Fig 1 · C21 · China Annual

Alzheimer's disease drug trial starts

China, 2020 to 2025

6 observations · 2020 to 2025
Alzheimer's disease drug trial startsAlzheimer's disease drug trial starts. 6 observations from 2020 to 2025, ranging from 5 to 16. Latest value 16 (2025). 0 5 10 15 20 2020 2021 2022 2023 2024 2025 6 16
Alzheimer's disease drug trial startsAlzheimer's disease drug trial starts. 6 observations from 2020 to 2025, ranging from 5 to 16. Latest value 16 (2025). 0 5 10 15 20 2020 2021 2022 2023 2024 2025 6 16
Alzheimer's disease drug trial startsAlzheimer's disease drug trial starts. 6 observations from 2020 to 2025, ranging from 5 to 16. Latest value 16 (2025). 0 5 10 15 20 2020 2021 2022 2023 2024 2025 6 16
View the underlying data
Alzheimer's disease drug trial starts
Period Type Value
2020 Actual 6
2021 Actual 12
2022 Actual 11
2023 Actual 5
2024 Actual 14
2025 Actual 16
Source: ClinicalTrials.gov · CC BY 4.0 · statorigin.org

Every record

70 records across 10 measures, newest first within each. Each period opens its record and quote.

Measure Period Value Source
Alzheimer's disease drug trial starts 2025 16 ClinicalTrials.gov
Alzheimer's disease drug trial starts 2024 14 ClinicalTrials.gov
Alzheimer's disease drug trial starts 2023 5 ClinicalTrials.gov
Alzheimer's disease drug trial starts 1 Jan 2023 to 27 Sep 2026 46 ClinicalTrials.gov
Alzheimer's disease drug trial starts 2022 11 ClinicalTrials.gov
Alzheimer's disease drug trial starts 2021 12 ClinicalTrials.gov
Alzheimer's disease drug trial starts 2020 6 ClinicalTrials.gov
Antibody-drug conjugate trial starts 2025 177 ClinicalTrials.gov
Antibody-drug conjugate trial starts 2024 150 ClinicalTrials.gov
Antibody-drug conjugate trial starts 1 Jan 2023 to 27 Sep 2026 638 ClinicalTrials.gov
Antibody-drug conjugate trial starts 2023 120 ClinicalTrials.gov
Antibody-drug conjugate trial starts 2022 69 ClinicalTrials.gov
Antibody-drug conjugate trial starts 2021 40 ClinicalTrials.gov
Antibody-drug conjugate trial starts 2020 25 ClinicalTrials.gov
Autoimmune cell therapy and T-cell engager trial starts 2025 76 ClinicalTrials.gov
Autoimmune cell therapy and T-cell engager trial starts 2024 51 ClinicalTrials.gov
Autoimmune cell therapy and T-cell engager trial starts 2023 9 ClinicalTrials.gov
Autoimmune cell therapy and T-cell engager trial starts 1 Jan 2023 to 27 Sep 2026 185 ClinicalTrials.gov
Autoimmune cell therapy and T-cell engager trial starts 2022 3 ClinicalTrials.gov
Autoimmune cell therapy and T-cell engager trial starts 2021 6 ClinicalTrials.gov
Autoimmune cell therapy and T-cell engager trial starts 2020 1 ClinicalTrials.gov
Cardiometabolic RNA and next-generation lipid drug trial starts 2025 12 ClinicalTrials.gov
Cardiometabolic RNA and next-generation lipid drug trial starts 2024 12 ClinicalTrials.gov
Cardiometabolic RNA and next-generation lipid drug trial starts 1 Jan 2023 to 27 Sep 2026 35 ClinicalTrials.gov
Cardiometabolic RNA and next-generation lipid drug trial starts 2023 7 ClinicalTrials.gov
Cardiometabolic RNA and next-generation lipid drug trial starts 2022 3 ClinicalTrials.gov
Cardiometabolic RNA and next-generation lipid drug trial starts 2021 4 ClinicalTrials.gov
Cardiometabolic RNA and next-generation lipid drug trial starts 2020 0 ClinicalTrials.gov
Gene editing trial starts 2025 14 ClinicalTrials.gov
Gene editing trial starts 2024 17 ClinicalTrials.gov
Gene editing trial starts 2023 13 ClinicalTrials.gov
Gene editing trial starts 1 Jan 2023 to 27 Sep 2026 54 ClinicalTrials.gov
Gene editing trial starts 2022 4 ClinicalTrials.gov
Gene editing trial starts 2021 2 ClinicalTrials.gov
Gene editing trial starts 2020 3 ClinicalTrials.gov
GLP-1, incretin multi-agonist and amylin trial starts 2025 54 ClinicalTrials.gov
GLP-1, incretin multi-agonist and amylin trial starts 2024 36 ClinicalTrials.gov
GLP-1, incretin multi-agonist and amylin trial starts 2023 40 ClinicalTrials.gov
GLP-1, incretin multi-agonist and amylin trial starts 1 Jan 2023 to 27 Sep 2026 178 ClinicalTrials.gov
GLP-1, incretin multi-agonist and amylin trial starts 2022 21 ClinicalTrials.gov
GLP-1, incretin multi-agonist and amylin trial starts 2021 18 ClinicalTrials.gov
GLP-1, incretin multi-agonist and amylin trial starts 2020 16 ClinicalTrials.gov
Inflammatory bowel disease drug trial starts 2025 31 ClinicalTrials.gov
Inflammatory bowel disease drug trial starts 2024 22 ClinicalTrials.gov
Inflammatory bowel disease drug trial starts 2023 16 ClinicalTrials.gov
Inflammatory bowel disease drug trial starts 1 Jan 2023 to 27 Sep 2026 101 ClinicalTrials.gov
Inflammatory bowel disease drug trial starts 2022 18 ClinicalTrials.gov
Inflammatory bowel disease drug trial starts 2021 12 ClinicalTrials.gov
Inflammatory bowel disease drug trial starts 2020 12 ClinicalTrials.gov
KRAS and RAS inhibitor trial starts 2025 24 ClinicalTrials.gov
KRAS and RAS inhibitor trial starts 2024 25 ClinicalTrials.gov
KRAS and RAS inhibitor trial starts 2023 16 ClinicalTrials.gov
KRAS and RAS inhibitor trial starts 1 Jan 2023 to 27 Sep 2026 91 ClinicalTrials.gov
KRAS and RAS inhibitor trial starts 2022 11 ClinicalTrials.gov
KRAS and RAS inhibitor trial starts 2021 8 ClinicalTrials.gov
KRAS and RAS inhibitor trial starts 2020 1 ClinicalTrials.gov
Oncology bispecific antibody trial starts 2025 153 ClinicalTrials.gov
Oncology bispecific antibody trial starts 2024 119 ClinicalTrials.gov
Oncology bispecific antibody trial starts 1 Jan 2023 to 27 Sep 2026 489 ClinicalTrials.gov
Oncology bispecific antibody trial starts 2023 105 ClinicalTrials.gov
Oncology bispecific antibody trial starts 2022 64 ClinicalTrials.gov
Oncology bispecific antibody trial starts 2021 41 ClinicalTrials.gov
Oncology bispecific antibody trial starts 2020 23 ClinicalTrials.gov
Radioligand therapy trial starts 2025 22 ClinicalTrials.gov
Radioligand therapy trial starts 2024 19 ClinicalTrials.gov
Radioligand therapy trial starts 2023 18 ClinicalTrials.gov
Radioligand therapy trial starts 1 Jan 2023 to 27 Sep 2026 75 ClinicalTrials.gov
Radioligand therapy trial starts 2022 9 ClinicalTrials.gov
Radioligand therapy trial starts 2021 6 ClinicalTrials.gov
Radioligand therapy trial starts 2020 2 ClinicalTrials.gov

Frequently asked questions

What is the latest clinical trial starts figure for China?

China: 16 alzheimer's disease drug trial starts in 2025, +14.3% on 2024.

Where does the China data come from?

70 records from 70 documents by ClinicalTrials.gov. Each figure links to its record and the sentence it was read from.

Cite this page

Free to reuse under CC BY 4.0 with attribution to StatOrigin and the original publisher.

StatOrigin. (2026). Clinical trial starts in China [Data set]. Retrieved September 29, 2026, from https://statorigin.org/statistics/clinical-trial-starts/china

"Clinical trial starts in China." StatOrigin, 2026, https://statorigin.org/statistics/clinical-trial-starts/china. Accessed 29 Sep. 2026.

StatOrigin. "Clinical trial starts in China." Data set, 2026. Accessed September 29, 2026. https://statorigin.org/statistics/clinical-trial-starts/china.

@misc{statorigin_clinical_trial_starts_china_2026, title = {Clinical trial starts in China}, author = {{StatOrigin}}, year = {2026}, url = {https://statorigin.org/statistics/clinical-trial-starts/china}, note = {Data set. Accessed 2026-09-29} }